First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462)

Human Reproduction

Volumn 13, Issue 2, 1998, Pages 294-295

  Itskovitz Eldor, J ^a   Kol, S ^a   Mannaerts, B ^b   Bennink, H Coelingh ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Organon International bv   (Netherlands)

Author keywords

Ganirelix; GnRH antagonist; Ovarian stimulation; Pregnancy; Recombinant human FSH

Indexed keywords

GANIRELIX; GONADORELIN ANTAGONIST; RECOMBINANT FOLLITROPIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; LUTEINIZING HORMONE RELEASE; MALE; MALE INFERTILITY; NEWBORN; OVULATION INDUCTION; PREGNANCY; SUBCUTANEOUS DRUG ADMINISTRATION; TWIN PREGNANCY;

EID: 0031937761     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.2.294     Document Type: Article

References (8)

1. Albano, C., Smitz, J., Camus, M. et al. (1996) Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix). Hum. Reprod., 11, 2114-2118.
2. Bouchard, P., Charbonnel,B., Caraty,A. et al. (1994) The role of GnRH during the preovulatory period: a basis for the use of GnRH antagonists in ovulation induction. In Filicori, M. and Flamingi, C. (eds), Ovulation Induction: Basic Science and Clinical Advances. Elsevier Science B.V. International Congress Series 1046, pp. 291-295.
3. Fraser, H.M., Lunn, S.F., Morris, K.D. and Deghenghi, R. (1997) Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge. Hum. Reprod., 12, 430-435.
4. Glasier, A., Thatcher, S.S., Wickings, E.J. et al. (1988) Superovulation with exogenous gonadotropins does not inhibit the luteinizing hormone surge. Fertil. Steril., 49, 81-85.
5. Nelson, L.R., Fujimoto, V.Y., Jaffe, R.B. and Monroe, S.E. (1995) Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropinreleasing hormone antagonist with reduced histamine-releasing properties (ganirelix). Fertil. Steril., 63, 963-969.
6. Out, H.J., Mannaerts, B.M., Driesseb, O.S. and Bennink, H.J. (1995) A prospective, randomized, assessor-blind multicentre study comparing recombinant and urinary follicle-stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum. Reprod., 10, 2534-2540.
7. Steptoe, P.C. and Edwards, R.G. (1978) Birth after the reimplantation of a human embryo. Lancet, ii (8085), 366.
8. Ubaldi, F., Albano, C., Peukert, M. et al. (1996) Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in intracytoplasmic sperm injection cycles. Hum. Reprod., 11, 1405-1407.